Medicare Enrolled
Dr. Mihir Raval, M.D. , M.P.H.
Hematology & Oncology · Albany, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Raval from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Raval?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Raval
Dr. Mihir Raval is a hematology & oncology specialist in Albany, NY, with 17 years of NPI registration. Based on federal Medicare data, Dr. Raval performed 24,292 Medicare services across 3,182 unique beneficiaries.
Between the years covered by Open Payments, Dr. Raval received a total of $648,821 from 28 pharmaceutical and/or device companies across 501 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Raval is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 18% volume in NY
$648,821 industry payments
Medicare Practice Summary
Medicare Utilization ↗24,292
Medicare services
Top 18% in NY for hematology & oncology
3,182
Unique beneficiaries
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,429 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
8,670 | $0 | $6 |
| Immune globulin infusion (Octagam) This procedure involves the administration of immune globulin medication directly into a vein. It is provided in a non-lyophilized liquid form. |
3,940 | $34 | $218 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
2,400 | $0 | $6 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,159 | $0 | $1 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
852 | $8 | $18 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
767 | $8 | $34 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
697 | $10 | $60 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
685 | $9 | $52 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
459 | $6 | $29 |
| Injection, granisetron hydrochloride, 100 mcg | 390 | $0 | $24 |
| Immunoassay substance measurement A laboratory test that uses immunoassay techniques to measure the level of a specific substance in a sample. |
362 | $17 | $181 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
362 | $90 | $217 |
| Anti-nausea injection (Aloxi/palonosetron) | 300 | $1 | $114 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
209 | $65 | $144 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
197 | $13 | $56 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
183 | $61 | $152 |
| Iron level test | 176 | $6 | $25 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
174 | $9 | $33 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
162 | $11 | $95 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
148 | $21 | $138 |
| Beta-2 microglobulin level test A blood test that measures the level of beta-2 microglobulin, a protein produced by cells in the body. |
140 | $16 | $90 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
125 | $15 | $88 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
125 | $54 | $186 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
116 | $6 | $32 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
115 | $4 | $20 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
107 | $46 | $276 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
103 | $98 | $622 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
89 | $1 | $7 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
77 | $15 | $72 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
76 | $10 | $84 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
65 | $21 | $141 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
65 | $2 | $19 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
49 | $4 | $28 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
46 | $25 | $226 |
| Plasma separation from blood A procedure that uses mechanical methods to separate plasma from whole blood. This process isolates the liquid portion of the blood for further testing or treatment. |
45 | $71 | $500 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 45 | $410 | $638 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
44 | $99 | $288 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
42 | $14 | $69 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
39 | $7 | $27 |
| Automated red blood cell count with calculations A blood test that automatically counts red blood cells and performs additional calculations to assess blood health. |
35 | $5 | $26 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
34 | $38 | $100 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
32 | $49 | $303 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
31 | $128 | $400 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
30 | $1,197 | $4,981 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
29 | $16 | $76 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
28 | $91 | $225 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
27 | $135 | $275 |
| Haptoglobin level test A blood test that measures the amount of haptoglobin, a protein in the serum. It helps evaluate red blood cell breakdown. |
23 | $12 | $62 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
22 | $29 | $250 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
20 | $97 | $208 |
| Hospital discharge management, 30+ min This service covers the care provided by a physician or qualified healthcare professional on the day a patient is discharged from the hospital. It requires more than 30 minutes of total time spent on the day of discharge. |
19 | $88 | $213 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
18 | $120 | $333 |
| New patient office visit, complex (60-74 min) | 18 | $168 | $419 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
16 | $4 | $23 |
| Whole body nuclear medicine scan with CT A combined imaging procedure using nuclear medicine and CT scans to visualize the entire body. |
15 | $1,189 | $4,981 |
| Hepatitis C antibody test A blood test that checks for antibodies to the hepatitis C virus. This test helps determine if a person has been exposed to the virus. |
14 | $14 | $85 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
14 | $64 | $148 |
| Hepatitis B core antibody test A blood test that measures the level of antibodies to the hepatitis B core antigen. This test helps determine if a person has been infected with the hepatitis B virus. |
13 | $12 | $74 |
| Hepatitis B surface antibody test A blood test that measures the level of antibodies against the hepatitis B surface antigen. This test is used to check for immunity to hepatitis B or to verify the effectiveness of the hepatitis B vaccine. |
13 | $11 | $59 |
| Hepatitis B surface antigen test A blood test that uses an immunoassay technique to detect the presence of the hepatitis B surface antigen. This test identifies whether the hepatitis B virus is currently present in the body. |
13 | $10 | $57 |
| PSA test (prostate cancer screening) | 12 | $18 | $88 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
11 | $9 | $61 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
54.5% high complexity
19.8% medium
25.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$648,821
Total received (2018-2024)
Avg $92,689/year across 7 years
Top 1% in NY for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
28
Companies
501
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$555,594 (85.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$92,763 (14.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$465 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$108,039
2023
$176,809
2022
$192,474
2021
$120,238
2020
$45,107
2019
$6,041
2018
$113
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GENZYME CORPORATION
$27,210
GlaxoSmithKline, LLC.
$23,034
AstraZeneca Pharmaceuticals LP
$16,901
E.R. Squibb & Sons, L.L.C.
$14,374
Takeda Pharmaceuticals U.S.A., Inc.
$8,188
ABBVIE INC.
$8,180
Alexion Pharmaceuticals, Inc.
$6,702
Incyte Corporation
$1,925
Agios Pharmaceuticals, Inc.
$705
Celgene Corporation
$699
Janssen Biotech, Inc.
$123
Top 3 companies account for 62.1% of 2024 payments
All-time payments by company (2018-2024) ›
Takeda Pharmaceuticals U.S.A., Inc.
$124,696
AstraZeneca Pharmaceuticals LP
$109,215
GlaxoSmithKline, LLC.
$66,105
GENZYME CORPORATION
$56,565
Incyte Corporation
$52,002
Alexion Pharmaceuticals, Inc.
$41,995
E.R. Squibb & Sons, L.L.C.
$37,178
Epizyme, Inc.,
$33,382
Adaptive Biotechnologies Corporation
$20,549
BeiGene USA, Inc.
$19,727
ADC Therapeutics America, Inc.
$18,792
ABBVIE INC.
$17,863
Ipsen Biopharmaceuticals, Inc
$11,938
Astellas Pharma US Inc
$7,835
AbbVie Inc.
$7,689
Celgene Corporation
$5,641
CTI BioPharma Corp.
$3,422
AbbVie, Inc.
$3,150
Lilly USA, LLC
$2,812
MorphoSys, US Inc.
$2,225
Agios Pharmaceuticals, Inc.
$2,215
PharmaEssentia USA Corporation
$1,845
JAZZ PHARMACEUTICALS INC.
$1,500
Janssen Biotech, Inc.
$215
Seagen Inc.
$124
PFIZER INC.
$111
Stemline Therapeutics Inc.
$17
Genentech USA, Inc.
$13
Top 3 companies account for 46.2% of all-time payments
Associated products mentioned in payments ›
BESPONSA · BESREMI · BLENREP · BOSULIF · BRUKINSA · CALQUENCE · CARVYKTI · DAURISMO · ELZONRIS · EPKINLY · IMFINZI · JAKAFI · MONJUVI · MYLOTARG · NINLARO · OJJAARA · ONUREG · PYRUKYND · Perjeta · Pomalyst · REBLOZYL · SARCLISA · TAGRISSO · TAZVERIK · TECVAYLI · Tazverik · ULTOMIRIS · Ultomiris · VELCADE · VENCLEXTA · VYXEOS · Venclexta · Vonjo · XOSPATA · Xospata · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (86%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology & oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for hematology & oncology in NY.
Geographic Context
Hematology & oncology specialists within 10 mi
37
Per 100K population
11.7
County median income
$83,149
Nearest hospital
ALBANY MEDICAL CENTER HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Raval is a mixed practice specialist, with above-average Medicare volume (top 18% in NY), with speaking/promotional industry engagement in the top 1% of NY peers, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Raval experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Raval performed 8,670 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Raval receive payments from pharmaceutical companies?
Yes. Dr. Raval received a total of $648,821 from 28 companies across 501 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Raval's costs compare to other hematology & oncology specialists in Albany?
Dr. Raval's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Raval) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Albany
Browse hematology & oncology specialists in Albany ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NY
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NY
Which NY hematology & oncology specialists receive the most from drug and device companies.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology